The content on this site is intended for healthcare professionals only
Driving the medicinal cannabis industry
Running a cancer hospital in rural Cameroon
Genomic trends across the African Diaspora for breast cancer
The latest advances from BioVentures for Global Health in Africa
Highlights from ASCO 2019
Potential of PARP inhibitors for metastatic breast cancer
Preventing brain metastases in patients with HER2 or triple negative breast cancer
Understanding eligibility criteria for clinical trials to increase study size
Long-term survival after laparoscopic versus open resection for colorectal liver metastases
Targeting agent enfortumab vedotin a novel treatment for patients with advanced urothelial cancer
Expanded clinical trial inclusion criteria would double the percentage of patients eligible to enrol in clinical trials
New agent targeting Nectin-4 produces responses in nearly half of patients with advanced urothelial cancer
